Pfizer 4Q10 4Q10 Revenues: $17.6 billion (+6%) 4Q10 Earnings: $2.9 billion (+277%) FY Revenues: $67.8 billion (+36%) FY Earnings: $8.3 billion (-4%) Comments: U.S. revenues dropped 3% in 4Q10 to $7.2 billion, while international sales were up 13% to $10.3 billion. For the year, revenues were up $17.8 billion, but the company received a boost of $18.1 billion from legacy Wyeth products and $1.1 billion from exchange rates. Legacy Pfizer products were down 3% for FY. The company ann...